A human serum albumin–thioredoxin fusion protein prevents experimental contrast-induced nephropathy

Kodama, A.; Watanabe, H.; Tanaka, R.; Tanaka, H.; Chuang, Victor; Miyamoto, Y.; Wu, Q.; Endo, M.; Hamasaki, K.; Ishima, Y.; Fukagawa, M.; Otagiri, M.; Maruyama, T.

View/Open

248912_83518_Chuang_KidneyInt_2013.pdf (918.5Kb)

Access Status

Fulltext not available

Authors

Kodama, A.

Watanabe, H.

Tanaka, R.

Tanaka, H.

Chuang, Victor

Miyamoto, Y.

Wu, Q.

Endo, M.

Hamasaki, K.

Ishima, Y.

Fukagawa, M.

Otagiri, M.

Maruyama, T.

Date

2013

Type

Journal Article

Metadata

Show full item record

Abstract

No Abstract available.

Citation

Kodama, A. and Watanabe, H. and Tanaka, R. and Tanaka, H. and Chuang, V. and Miyamoto, Y. and Wu, Q. et al. 2013. A human serum albumin–thioredoxin fusion protein prevents experimental contrast-induced nephropathy. Kidney International. 83: pp. 446-454.

Source Title

Kidney International

URI

http://hdl.handle.net/20.500.11937/49488

Additional URLs

http://www.nature.com/ki/index.html

Department

School of Pharmacy

Collections

Research Papers